ENDRA Life Sciences Statistics
NASDAQ: NDRAHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
5.46-0.47 (-7.93%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ENDRA Life Sciences by the numbers
ENDRA Life Sciences has a market capitalization of $8.2 million based on 1.50M shares outstanding. With trailing EPS of $-6.26, ENDRA Life Sciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.4% above its 50-day average and 13.9% above its 200-day average.
Average daily trading volume is 34.18K shares, or about $186,617 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NDRA valuation vs. peer median
| Metric | NDRA | Peer median | Difference |
|---|---|---|---|
| Market cap | $8.19M | $22.69M | -64% |
| Avg. volume | 34.18K | 274.80K | -88% |
Peer median across 8 companies: VBIO, NXL, NUWE, IRIX, ITOC, QTI, POCI, OM.
Valuation
- Market cap
- $8.19M
- EPS (TTM)
- $-6.26
- Shares outstanding
- 1.50M
Price and trading
- Previous close
- 5.93
- Open
- 5.81
- Day range
- 5.32 – 6.02
- 52-week range
- 2.96 – 9.85
- Beta
- —
- Volume
- 23.05K
- Average volume
- 34.18K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 20, 2025
Additional statistics
- Market Cap
- 8.19M
- Forward Pe
- -1.80
- Eps
- -6.26
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.85
- Week52 Low
- 2.96
- Avg Volume
- 34,179.00
- Shares Outstanding
- 1.50M
- Ma50
- 5.33
- Ma200
- 4.79
- Earnings Date
- Aug 20, 2025
- Pct From52w High
- -44.57%
- Pct From52w Low
- 84.46%